Physician Assistant · Phoenix, AZ
NPI
1437280658
Since 2007
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
5779 E Mayo Blvd
Phoenix, AZ, 85054
Phone (480) 301-8000
Groups this clinician bills Medicare through
Medicare paid, 2024
$98K
1,537 services
Medicare patients, 2024
559
Average age 75
Drug cost, 2024
$3.0M
710 prescriptions
Company payments, 2025
$156
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Joshua L Blocher was code 99214 (office e&m - established), 624 times for 391 patients. In total Joshua L Blocher billed 1,537 services in 11 codes, and Medicare paid $98K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-04-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 624 | 391 | $77.30 | $48K |
| 99213 Office E&M - Established | Office | 315 | 209 | $54.08 | $17K |
| 99215 Office E&M - Established | Office | 154 | 124 | $113.40 | $17K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 122 | 82 | $10.60 | $1,294 |
| 99442 Telephone Services | Office | 14 | 12 | $55.10 | $771 |
By year: 2022 $34K for 384 services; 2023 $84K for 1,247 services; 2024 $98K for 1,537 services.
Medicare prescription drug claims, 2024
In 2024, the drug Joshua L Blocher prescribed most often to Medicare patients was Venclexta (Venetoclax), with 150 prescriptions and refills. In total Joshua L Blocher wrote 710 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Venclexta Venetoclax | 150 | 150 | 25 | $1.8M |
| Acyclovir Generic | 81 | 243 | 40 | $1,914 |
| Pegasys Peginterferon Alfa-2a | 59 | 59 | Under 11 | $171K |
| Hydroxyurea Generic | 54 | 150 | 19 | $1,776 |
| Prednisone Generic | 35 | 40 | 21 | $178 |
| Eliquis Apixaban | 34 | 54 | Under 11 | $32K |
| Omeprazole Generic | 31 | 50 | 22 | $198 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 26 | 66 | Under 11 | $340 |
| Imbruvica Ibrutinib | 22 | 22 | Under 11 | $292K |
| Brukinsa Zanubrutinib | 21 | 21 | Under 11 | $251K |
| Doxycycline Monohydrate Generic | 19 | 19 | 19 | $161 |
| Triamcinolone Acetonide Generic | 19 | 21 | Under 11 | $343 |
| Calquence Acalabrutinib Maleate | 12 | 12 | Under 11 | $186K |
Brand drugs: 330 claims; generic drugs: 380 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Joshua L Blocher $156 ($156 in general payments such as food, travel and fees) from 1 company. The largest payer was Celgene Corporation with $156.
| Company | Payments | Amount |
|---|---|---|
| Celgene Corporation BMY | 7 | $156 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.